Given the highly homogeneous nature of MTAP deficiency, this difference cannot be explained by the higher number of samples (n = 5) that were analyzed per tumor in our “heterogeneity TMA” or the whole section approach in 41 cases. The gene discussed is MTAP; the disease is neoplasm.